Formosa Laboratories, Inc., conveniently located in suburban Taipei, produces API and intermediates under cGMP in its modern FDA-inspected facilities. Formosa API products include Vitamin D analogues, balsalazide, capsaicin, montelukast, mycophenolate mofetil, Sevelamer, etc. Formosa has strong R&D capability and experience, with 43 out of a total of 140 employees doing either process development or analytical method development. Custom synthesis service is offered under strict confidentiality from lab scale to commercial production, with full documentation support (filed 10 US DMF's, 1 CEP, and multiple EU DMF's). Production equipment of either SS or GL ranges from 50 L to 8,000 L in size.
